Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-06-23
1986-01-21
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514824, A61K 3144
Patent
active
045658234
ABSTRACT:
A medical agent for suppressing arteriosclerosis or a hypolipemic agent comprising a composition containing nicardipine or a pharmaceutically acceptable salt thereof as the effective component.
REFERENCES:
patent: 4150119 (1979-04-01), Lalinde
patent: 4343789 (1982-08-01), Kawata et al.
patent: 4404183 (1983-09-01), Kawata et al.
Chemical Abstracts; vol. 87; (1977), #127576u; Seki et al., Pharmacological Evaluation of YC-93, "A New Vasodilator, in Healthy Volunteers".
Chemical Abstracts; vol. 91; (1979), #168498w; Takenaka et al.
Chemical Abstracts; vol. 82; (1975) #4131j; Murakami et al.
Life Sciences, vol. 32, pp. 557-563; DeFeudis, "Calcium-Antagonists" and Atherosclerosis-Basic Studies and Therapeutic Implications (1983).
Laboratory Investigation, vol. 49, No. 2, pp. 154-158; Ginsburg et al.; "Calcium Antagonists Suppress Atherogenesis . . . " (1983).
Chemical Abstracts vol. 95, (1981); 275e; Michic et al.
Chemical Abstracts vol. 98 (1983); 141330t; Takahashi et al.
Ohata Isao
Sakamoto Nobuo
Lipovsky Joseph A.
Schenkman Leonard
Yamanouchi Pharmaceutical Co. Ltd.
LandOfFree
Medical agent for suppressing arteriosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical agent for suppressing arteriosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical agent for suppressing arteriosclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2298744